Heterozygosity in CTLA-4 gene and severe preeclampsia

International Journal of Gynecology and Obstetrics

Volumn 88, Issue 1, 2005, Pages 19-24

  Samsami Dehaghani, A ^a   Doroudchi, M ^a,b   Kalantari, T ^b   Pezeshki, A M ^b   Ghaderi, A ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CTLA 4; Exon 1; Polymorphism; Preeclampsia

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GENOMIC DNA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BLOOD; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 11144249312     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2004.09.007     Document Type: Article

References (28)

1. D.J. Taylor P.C. Rubin The epidemiology of hypertension during pregnancy 1988 Amsterdam Elsevier 223 240
2. National Institutes of Health (U.S.). Working Group report on high blood pressure in pregnancy. NIH publication no. 00-3029, Bethesda; 2000.
3. G.A. Dekker, P.Y. Robillard, and T.C. Hulsey Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies Obstet. Gynecol. Surv. 53 1998 377 382
4. G.A. Dekker, and B.M. Sibai The immunology of pre-eclampsia Semin. Perinatol. 23 1999 24 33
5. Y. Yoneyama, S. Suzuki, R. Sawa, K. Yoneyama, G.G. Power, and T. Araki Relation between adenosine and T-helper 1/T-helper 2 imbalance in women with pre-eclampsia Obstet. Gynecol. 99 2002 641 646
6. S. Saito, H. Umekage, Y. Sakamoto, M. Sakai, K. Tanebe, and Y. Sasaki Increased Th1-type immunity and decreased Th2-type immunity in patients with pre-eclampsia Am. J. Reprod. Immunol. 41 1999 297 306
7. L.C. Chesley, and D.W. Cooper Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women Br. J. Obstet. Gynaecol. 93 1986 898 908
8. R. Arngrimsson, H. Bjornsson, and R.T. Geirsson Analysis of different inheritance patterns in pre-eclampsia/eclampsia syndrome Hypertens. Pregnancy 14 1995 27 38
9. A.F. Tsai, K.A. Kaufman, M.A. Walker, T.G. Karrison, R.R. Odem, and R.B. Barnes Transmission disequilibrium of maternally-inherited CTLA-4 microsatellite alleles in idiopathic recurrent miscarriage J. Reprod. Immunol. 40 1998 147 157
10. T. Takahashi, T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, and N. Sakaguchi Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4 J. Exp. Med. 192 2000 303 310
11. S.F. Oluwole, O.O. Oluwole, H.A. DePaz, A.O. Adeyeri, P. Witkowski, and M.A. Hardy CD4+CD25+ regulatory T cells mediate acquired transplant tolerance Transpl. Immunol. 11 2003 287 293
12. P. de Reuver, V. Pravica, W. Hop, P. Boor, H.J. Metselaar, and I.V. Hutchinson Recipient CTLA-4 +49G/G genotype is associated with reduced incidence of acute rejection after liver transplantation Am. J. Transplant. 3 2003 1587 1594
13. K.A. Kaufman, J.A. Bowen, A.F. Tsai, J.A. Bluestone, J.S. Hunt, and C. Ober The CTLA-4 gene is expressed in placental fibroblasts Mol. Hum. Reprod. 5 1999 84 87
14. E.K. Moses, J.A. Lade, G. Guo, A.N. Wilton, M. Grehan, and K. Freed A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2 Am. J. Hum. Genet. 67 2000 1581 1585
15. R. Arngrimsson, S. Sigurard ttir, M.L. Frigge, RI.. Bjarnad ttir, T. Jonsson, and H. Stefansson A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13 Hum. Mol. Genet. 8 1999 1799 1805
16. A. Ligers, N. Teleshova, T. Masterman, W.X. Huang, and J. Hillert CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms Genes Immun. 2 2001 145 152
17. X.B. Wang, M. Kakoulidou, R. Giscombe, Q Qiu, D. Huang, and R. Pirskanen Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of AT-rich gene sequence J. Neuroimmunol. 130 2002 224 232
18. S.A. Miller, D.D. Dykes, and H.F. Polesky A simple salting out procedure for extracting DNA from human nucleated cells Nucleic Acids Res. 16 1988 1215
19. H. Donner, J. Braun, C. Seidl, H. Rau, R. Finke, and M. Ventz Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease J. Clin. Endocrinol. Metab. 82 1997 4130 4132
20. T. Kalantari, H. Mostafavi, A.M. Pezeshki, S. Farjadian, M. Doroudchi, and F. Yeganeh Exon-1 polymorphism of CTLA-4 gene in Iranian patients with Graves' disease Autoimmunity 36 2003 313 316
21. J.L. Fleiss Statistical methods for rates and proportions 2nd Ed. 1981 John Willey and Sons Publications 138
22. M.F. Krummel, and J.P. Allison CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells J. Exp. Med. 183 1996 2533 2540
23. M.C. Brunner, C.A. Chambers, F.K. Chan, J. Hanke, A. Winoto, and J.P. Allison CTLA-4-mediated inhibition of early events of T cell proliferation J. Immunol. 162 1999 5813 5820
24. H. Bour-Jordan, J.L. Grogan, Q. Tang, J.A. Auger, R.M. Locksley, and J.A. Bluestone CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment Nat. Immunol. 4 2003 182 188
25. H.F. Harbo, E.G. Celius, F. Vartdal, and A. Spurkland CTLA-4 promoter and exon 1 dimorphisms in multiple sclerosis Tissue Antigens 53 1999 106 110
26. M.F. Gonzalez-Escribano, R. Rodriguez, A. Valenzuela, A. Garcia, J.R. Garcia-Lozano, and A. Nunez-Roldan CTLA-4 polymorphisms in Spanish patients with rheumatoid arthritis Tissue Antigens 53 1999 296 300
27. J.C. Delgado, A. Baena, S. Thim, and A.E. Goldfeld Ethnic-specific genetic associations with pulmonary tuberculosis J. Infect. Dis. 186 2002 1463 1468
28. K. Tamura, M. Suzuki, H. Arakawa, K. Tokuyama, and A. Morikawa Linkage and association studies of STAT6 gene polymorphisms and allergic diseases Int. Arch. Allergy Immunol. 131 2003 33 38